Fact checked byJohn C. Schoen, MA

Read more

March 25, 2024
1 min read
Save

Top in cardiology: Risk of intermittent fasting; Tryvio approved for hypertension

Fact checked byJohn C. Schoen, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Eating during an 8-hour window carries a higher risk for cardiovascular death compared with the average eating window in the United States of 12 to 16 hours.

“Restricting daily eating time to a short period, such as 8 hours per day, has gained popularity in recent years as a way to lose weight and improve heart health,” Victor Wenze Zhong, PhD, professor and chair of the department of epidemiology and biostatistics at the Shanghai Jiao Tong University School of Medicine in China, said in a press release. “It’s crucial for patients, particularly those with existing heart conditions or cancer, to be aware of the association between an 8-hour eating window and increased risk of cardiovascular death.”

Intermittent_Fasting_Adobe
Eating during an 8-hour window carries a higher risk for cardiovascular death compared with the average eating window in the U.S. of 12 to 16 hours. Image: Adobe Stock

It was the top story in cardiology last week.

In another top story, the FDA approved Tryvio (aprocitentan, Idorsia) for the patients whose hypertension is not controlled by other drugs. The endothelin A/endothelin B receptor antagonist is the first oral drug with a new therapeutic pathway to receive approval for hypertension in nearly 40 years.

Read these and more top stories in cardiology below:

Intermittent fasting tied to increased risk for death from heart disease

A time-restricted eating window of less than 8 hours was associated with increased risk for cardiovascular death, according to study findings. Read more.

FDA approves Tryvio for treatment of hypertension in adults with uncontrolled BP

Idorsia announced that the FDA has approved Tryvio, its antihypertensive drug, for treatment of hypertension in combination with other drugs in patients whose BP is not adequately controlled on other drugs. Read more.

Extreme heat exposure may impair immune response, increase inflammation

Researchers identified mechanisms by which heat exposure caused immune response that may increase inflammation. Read more.

Virus that causes COVID-19 can damage heart even if heart tissue not directly affected

Among patients who died of acute respiratory distress syndrome associated with SARS-CoV-2, the virus that causes COVID-19, heart tissues were damaged even when they were not directly affected by the virus, researchers reported. Read more.

Childhood ‘lazy eye’ may be tied to future cardiometabolic risk

Childhood amblyopia, or “lazy eye,” was associated with increased likelihood of cardiometabolic risk factors in adulthood and a potential for increased risk for heart attack and death, researchers reported. Read more.